The goal of this application is to analyze the role of beta antithrombin in the hyperinflammation phase of COVID-19 patients.
Patients suffering from severe COVID-19 often experience symptoms of coagulopathy. The identification of coagulation factors that are involved in causing these complications may be of use for the development of novel therapeutic approaches against COVID-19.
|Effective start/end date||2020/12/01 → …|
UKÄ subject classification
- Infectious Medicine